Frederick Tay
Frederick is with the firm’s corporate practice, specialising in mergers and acquisitions and corporate transactions. He has more than 10 years of experience in the healthcare and consumer healthcare industry.
In the healthcare and life sciences industry, Frederick has advised and implemented both operational and transactional solutions for companies which include advising on supply contracts for active pharmaceutical ingredients in the manufacturing process, pricing and supply of medicines contracts with both public and private healthcare practices, advising on cross-border transactions globally, and advising on digital projects.
Contact Information:
All Posts:
Read Here
Advertise
Sign Up
Commentary
Where does value creation really happen?
Managing the cost of diverging standards: Why Singapore matters
Singapore’s AI ambition has an intelligence problem
Singapore is deploying AI at speed – and security risks are catching up
Precious metal boom is a stress test for Singapore’s gold ambitions
Singapore’s global dispute fault lines
‘Tokenmaxxing’ – The wrong AI race to run in Singapore
To outsmart modern fraud, we must first know the enemy
Why Singapore SMEs cannot wait for quantum cyber risk to arrive before securing data